{"status":"OK","data":{"id":2970173,"identifier":"DVN/CLOHZ0","persistentUrl":"https://doi.org/10.7910/DVN/CLOHZ0","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2017-02-15","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/CLOHZ0","latestVersion":{"id":97100,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/CLOHZ0","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2017-02-15T10:41:05Z","releaseTime":"2017-02-15T10:41:05Z","createTime":"2017-01-12T02:27:34Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Intellia Therapeutics CRISPR Patent Licenses and Press Releases"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Sherkow, Jacob"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"New York Law School"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Sherkow, Jacob"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"New York Law School"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"jacob.sherkow@nyls.edu"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This dataset contains PDFs of CRISPR patent licenses, and press releases containing patent license information, originating from Intellia Therapeutics, Cambridge, MA."}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Law","Medicine, Health and Life Sciences"]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Sherkow, Jacob"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2017-01-11"}]}},"files":[{"label":"Intellia to Novartis License, SEC.pdf","restricted":false,"version":1,"datasetVersionId":97100,"dataFile":{"id":2970175,"persistentId":"doi:10.7910/DVN/CLOHZ0/IBRRUP","pidURL":"https://doi.org/10.7910/DVN/CLOHZ0/IBRRUP","filename":"Intellia to Novartis License, SEC.pdf","contentType":"application/pdf","filesize":458143,"storageIdentifier":"s3://dvn-cloud:15990801b69-78fceb910501","rootDataFileId":-1,"md5":"c47aff9926a7e472e89337122cc458d4","checksum":{"type":"MD5","value":"c47aff9926a7e472e89337122cc458d4"}}},{"label":"Intellia to Regeneron License, SEC.pdf","restricted":false,"version":1,"datasetVersionId":97100,"dataFile":{"id":2970174,"persistentId":"doi:10.7910/DVN/CLOHZ0/LZ23CO","pidURL":"https://doi.org/10.7910/DVN/CLOHZ0/LZ23CO","filename":"Intellia to Regeneron License, SEC.pdf","contentType":"application/pdf","filesize":699192,"storageIdentifier":"s3://dvn-cloud:15990802044-663bdf94b986","rootDataFileId":-1,"md5":"23b449737e589902b54279a2a7b1b07c","checksum":{"type":"MD5","value":"23b449737e589902b54279a2a7b1b07c"}}}]}}}